PO.PR02.02 · 预防研究
解码错配修复缺陷型结直肠癌发生中免疫微环境的空间构筑
Decoding the spatial architecture of the immune microenvironment in mismatch repair-deficient colorectal carcinogenesis
该海报暂无可下载的资料
AACR 官方页面
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
引言:Lynch综合征(LS)是最常见的遗传性结直肠癌综合征,继发于错配修复(MMR)基因的胚系突变。在获得第二次体细胞打击后,上皮细胞变为MMR缺陷型(MMRd),并在微卫星位点累积大量indel突变,产生移码肽(突变的新抗原)。这些新抗原激活强劲的免疫反应并促进特异性T细胞克隆型的扩增。然而,免疫-上皮区室的空间组织,以及MMR缺失如何塑造早期免疫监视和逃逸,仍不清楚。
方法:我们利用空间转录组学解析了LS癌症发生轴上的免疫微环境,从我们在MD Anderson的LS队列中检测了5,000余个基因和27个LS新抗原特异性TCR克隆型。我们共研究了来自23例LS病例和15例散发病例的41份结直肠活检样本,这些样本排列于组织芯片上,并根据MMR状态和恶性程度进行分析,从而代表了迄今为止在LS背景下产生的最大空间转录组数据集。
结果:使用Xenium平台进行的空间分析在LS和散发样本中识别出不同的上皮、免疫和基质结构域。相较于正常黏膜,腺瘤显示出增殖性转运扩增上皮、癌症干样细胞、REG4+上皮的扩增,以及向M2b富集巨噬细胞的转变,与早期免疫调节的迹象一致。新抗原特异性TCR沿病理轴增加,并定位于异型增生腺体附近。MMRd腺瘤显示出活化单核细胞/巨噬细胞、浆细胞、炎性上皮的富集,以及干扰素应答和细胞因子介导通路的广泛诱导,从而反映出强劲的固有免疫和适应性免疫。MMRd病变中的CD8+ T细胞还表达更高水平的CTLA-4,提示活化诱导的抑制性信号传导和早期耗竭。与散发样本相比,LS组织显示出更强的免疫激活、更大的炎症和重塑邻域,以及更多的巨噬细胞和浆细胞浸润。多个新抗原特异性TCR克隆仅出现在LS病变中,支持免疫监视增强。
结论:空间转录组学揭示了由病理进展、MMR缺失和LS背景驱动的上皮、免疫和基质邻域的协调重塑。这些空间模式为LS肿瘤进展过程中的免疫-上皮相互作用提供了见解,确立了可为遗传性胃肠综合征的监视和免疫拦截策略提供依据的空间生物标志物,例如基于新抗原的疫苗接种,以增强MMRd癌症中肿瘤特异性T细胞的扩增、浸润和效应功能。
查看英文原文 English abstract
Introduction: Lynch Syndrome (LS) is the most common hereditary colorectal cancer syndrome and is secondary to germline mutations in the mismatch repair (MMR) genes. Upon acquiring a second somatic hit, epithelial cells become MMR-deficient (MMRd) and accumulate high number of indel mutations in microsatellite loci, generating frameshift peptides (mutated neo-antigens). These neo-antigens activate robust immune responses and promote the expansion of specific T-cell clonotypes. However, the spatial organization of immune-epithelial compartments, and how MMR loss shapes early immune surveillance and escape, remains unclear.
Methods: We dissected the immune microenvironment across the LS carcinogenesis axis using spatial transcriptomics to interrogate over 5,000 genes and 27 LS neoantigen-specific TCR clonotypes from our LS cohort at MD Anderson. We studied a total of 41 colorectal biopsies from 23 LS and 15 sporadic cases that were arranged in tissue microarrays and analyzed according to MMR status and malignancy, thus representing the largest spatial transcriptomic dataset generate to date in the context of LS.
Results: Spatial profiling using Xenium platform identified distinct epithelial, immune, and stromal domains across LS and sporadic samples. Relative to normal mucosa, adenomas showed expansion of proliferating transit-amplifying epithelium, cancer stem-like cells, REG4 + epithelia, and a shift toward M2b-enriched macrophages, consistent with signs of early immune modulation. Neo-antigen-specific TCRs increased along the pathology axis and localized near dysplastic glands. MMRd adenomas displayed enrichment of activated monocytes/macrophages, plasma cells, inflammatory epithelium, and broad induction of interferon-responsive and cytokine-mediated pathways, thus reflecting strong innate and adaptative immunity. CD8 + T cells in MMRd lesions also expressed higher CTLA-4 levels, indicating activation-induced inhibitory signaling and early exhaustion. Compared to sporadic samples, LS tissues showed stronger immune activation, larger inflammatory and remodeling neighborhoods, and increased macrophage and plasma-cell infiltration. Multiple neo-antigen-specific TCR clones appeared exclusively in LS lesions, supporting enhanced immune surveillance.
Conclusions: Spatial transcriptomics reveals coordinated remodeling of epithelial, immune, and stromal neighborhoods driven by pathology progression, MMR loss, and LS background. These spatial patterns provide insights into immune-epithelial interactions during LS neoplasm progression, establishing spatial biomarkers that may inform surveillance and immune interception strategies in hereditary gastrointestinal syndromes, such neo-antigen-based vaccination for boosting the expansion, infiltration, and effector function of tumor-specific T cells in MMRd cancers.
利益披露 Disclosure
A. Martel-Martel, None..
N. Deng, None..
M. Taggart, None..
A. Garcia-Gonzalez, None..
J. Thompson, None..
L. Ricciardiello, None..
Y. You, None..
S. Thirumurthi, None..
K. Sinha, None..
E. Vilar, None.